(19)
(11)
EP 0 836 610 A1
(12)
(43)
Date of publication:
22.04.1998
Bulletin 1998/17
(21)
Application number:
96922034.0
(22)
Date of filing:
26.06.1996
(51)
International Patent Classification (IPC):
C07H
7/
02
( . )
A61K
31/
7028
( . )
A61P
7/
02
( . )
A61P
9/
10
( . )
A61P
11/
16
( . )
A61P
35/
00
( . )
C07H
17/
02
( . )
A61K
31/
70
( . )
A61K
31/
7034
( . )
A61P
9/
08
( . )
A61P
11/
00
( . )
A61P
29/
00
( . )
C07H
15/
207
( . )
(86)
International application number:
PCT/EP1996/002785
(87)
International publication number:
WO 1997/001569
(
16.01.1997
Gazette 1997/04)
(84)
Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
(30)
Priority:
29.06.1995
CH 19950001914
(71)
Applicant:
Novartis AG
4058 Basel (CH)
(72)
Inventor:
KOLB, Hartmuth, Christian
D-79540 Lörrach (DE)
(74)
Representative:
Roth, Bernhard M., et al
Novartis AG Geistiges Eigentum Konzern Patent- und Markenabteilung CH Postfach
4002 Basel
4002 Basel (CH)
(54)
DIGLYCOSYLATED 1,2-DIOLS AS MIMETICS OF SIALYL-LEWIS X AND SIALYL-LEWIS A